- Article metrics
- Last updated: Fri, 19 Apr 2024 2:10:21 Z
A prospective, open-label, non-comparative study of palivizumab prophylaxis in children at high risk of serious respiratory syncytial virus disease in the Russian Federation
Access & Citations
-
- 2881
- Article Accesses
-
- 0
- Web of Science
-
- 11
- CrossRef
Citation counts are provided from Web of Science and CrossRef. The counts may vary by service, and are reliant on the availability of their data. Counts will update daily once available.